Concepedia

Joan T. Garrett

JT

18

Publications

1.5K

Citations

17

H-Index

2007

Active since

Affiliations

Vanderbilt University(Current)

University of Cincinnati Medical Center

University of Cincinnati

Breast Cancer Research Foundation

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Joan T. Garrett is an author at Vanderbilt University specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2007–2021

18

Publications

18

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

Joan T. Garrett, Maria G. Olivares, Cammie Rinehart et al. · Proceedings of the National Academy of Sciences · 2011 · 455 citations · Full text

, , +20

HER3 signaling and targeted therapy in cancer

Rosalin Mishra, Hima Patel, Samar Alanazi et al. · Oncology Reviews · 2018 · 181 citations · Full text

An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin

Andrew P. Garner, Carl Uli Bialucha, Elizabeth R. Sprague et al. · Cancer Research · 2013 · 121 citations · Full text

, , +12

Dual Blockade of HER2 in HER2-Overexpressing Tumor Cells Does Not Completely Eliminate HER3 Function

Joan T. Garrett, Cammie R. Sutton, M. Gabriela Kuba et al. · Clinical Cancer Research · 2012 · 97 citations · Full text

HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

Ariella B. Hanker, Joan T. Garrett, Mónica V. Estrada et al. · Clinical Cancer Research · 2017 · 97 citations · Full text

Rows per page

1–5 of 18